A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen
Top Cited Papers
- 1 June 2004
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 5 (6), 607-616
- https://doi.org/10.1016/j.ccr.2004.05.015
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast CancerNew England Journal of Medicine, 2003
- Antiestrogen resistance in breast cancer and the role of estrogen receptor signalingOncogene, 2003
- Breast cancer classification and prognosis based on gene expression profiles from a population-based studyProceedings of the National Academy of Sciences, 2003
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- The HOX Homeodomain Proteins Block CBP Histone Acetyltransferase ActivityMolecular and Cellular Biology, 2001
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Histologic Grading of Breast Cancer: Linkage of Patient Outcome with Level of Pathologist AgreementLaboratory Investigation, 2000
- High-Specificity In-Situ Hybridization Methods and ApplicationDiagnostic Molecular Pathology, 1992